Supplemental Figure 4 from Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer Atish D. Choudhury , Lucia Kwak , Alexander Cheung , Kathryn M. Allaire , Jaqueline Marquez , David D. Yang , Abhishek Tripathi , Jacqueline M. Kilar , Meredith Flynn , Brianna Maynard , Rebecca Reichel , Amanda F. Pace , Brandon K. Chen , Eliezer M. Van Allen , Kerry Kilbridge , Xiao X. Wei , Bradley A. McGregor , Mark M. Pomerantz , Rupal S. Bhatt , Christopher J. Sweeney , Glenn J. Bubley , Heather A. Jacene , Mary-Ellen Taplin , Franklin W. Huang , Lauren C. Harshman , Lawrence Fong crossref（2024）
摘要
Changes in A. CD4+FoxP3- effector cells and B. ratio of CD8+ to CD4+/FoxP3+ (Treg) cells from baseline to 8 weeks on treatment
更多 查看译文
AI 理解论文
溯源树
样例
